EQT

Avidicure is a cancer care company focused on enhancing immune system function through innovative therapies. It is developing a novel antibody modality known as "AVC-Boosters," which are dual agonistic and multifunctional, engineered to deliver targeted and effective monotherapy. This approach aims to provide broad applicability in oncology, addressing various cancer types while prioritizing safety and efficacy. Currently, Avidicure is operating in stealth mode, indicating a focus on research and development before public engagement.

EAGLE RAILCAR SERVICES is one of the nation's leading independent providers of railcar repair services.

ReliaQuest is a cybersecurity company based in Tampa, Florida, founded in 2007. It specializes in providing a cloud-native security platform called GreyMatter, which offers a comprehensive solution for minimizing data loss and business disruptions. The platform enhances visibility across Security Information and Event Management (SIEM), Endpoint Detection and Response (EDR), and multi-cloud environments, facilitating faster detection and response to security threats. By automating processes throughout the security lifecycle, ReliaQuest enables organizations to manage their security investments effectively and make informed decisions regarding their cybersecurity posture. The company's offerings are designed to protect enterprise environments from security breaches while ensuring compliance and enhancing overall security confidence.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

TravelPerk is a comprehensive platform designed to streamline business travel management by consolidating booking, reporting, and support into a single solution. The platform offers a diverse selection of travel options, including flights, hotels, and car rentals, which allows users to book their travel easily while adhering to company policies. It features an automated system that integrates customer service, reporting tools, and expense management capabilities, enabling organizations to oversee their travel arrangements effectively. Additionally, TravelPerk's technology facilitates the enforcement of travel policies, cost control, and data analysis, ultimately simplifying the travel planning process for businesses and their employees.

Cornerstone Robotics is dedicated to enhancing the accessibility of advanced medical services in China through the development of medical robotic devices. The company is focused on creating a safe and efficient surgical robotics platform aimed at improving the accuracy and efficiency of surgical operations. By prioritizing research and development, Cornerstone Robotics enables physicians to perform surgeries with greater precision, ultimately contributing to better patient outcomes in the healthcare sector.

Scale Microgrid Solutions, Inc. is a company that designs, builds, operates, and finances on-site power systems for commercial and industrial facilities across North America. Founded in 2016 and based in Ridgewood, New Jersey, the company specializes in multi-resource clean energy microgrids that support both daily operations and power outage scenarios. Its innovative offerings include the rapid response modular microgrid system, which optimizes solar photovoltaic energy, battery storage, and dispatchable generation. By providing fully-financed microgrid solutions, Scale Microgrid Solutions aims to deliver sustainable, reliable power while simplifying the microgrid development process for its customers.

XyloCor Therapeutics, based in Newtown Square, Pennsylvania, is a biopharmaceutical company dedicated to developing gene therapies for the treatment of cardiovascular diseases, particularly advanced coronary artery disease. Its lead product candidate, XC001, is currently in clinical development for patients suffering from refractory angina, addressing critical unmet medical needs for those who have exhausted conventional treatment options. Additionally, the company is developing XC002, aimed at regenerating cardiac tissue in patients with compromised heart function due to previous heart attacks and resultant heart failure. XyloCor's innovative gene therapy technologies focus on stimulating the formation of new coronary blood vessels, thereby improving blood supply to areas of the heart that are insufficiently perfused. The company collaborates with Weill Cornell Medical College to enhance its therapeutic approaches and outcomes for patients.

Noema Pharma AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company focuses on developing therapeutic products and therapies for orphan neurological disorders characterized by imbalanced neuronal networks. Its research and development efforts aim to address disabling symptoms in conditions affecting the nervous system, including Tuberous Sclerosis Complex, Trigeminal Neuralgia, and Tourette syndrome. By creating novel therapies, Noema Pharma seeks to improve the quality of life and patient outcomes for individuals suffering from these rare conditions.

Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.

NUA Surgical is an innovative start-up located at the Innovation Hub in Galway, Ireland, focused on enhancing women's health through advanced medical devices. The company has developed a patented surgical retractor specifically designed to improve the safety and efficiency of cesarean deliveries. By concentrating on research and development, NUA Surgical aims to provide obstetricians with tools that facilitate superior surgical outcomes, ultimately making C-sections safer for patients.

JUNIZ focuses on sustainable real estate and renewable energy solutions, including large-scale energy storage systems.

Calisen plc is a company based in Manchester, United Kingdom, that owns and manages essential energy infrastructure assets. It operates through two primary business units: Calvin Capital and Lowri Beck. Calvin Capital focuses on procuring, owning, and managing a portfolio of electricity and gas meters, primarily smart meters, for energy retailers. Meanwhile, Lowri Beck provides installation, meter reading, maintenance services, and ancillary support, such as customer service and call center operations, also on behalf of energy retailers. Calisen aims to capitalize on the UK government's initiative to roll out smart meters and is committed to supporting a cleaner and more sustainable energy sector by offering innovative services, including electric vehicle charging solutions. The company was incorporated in 2020.

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

PageUp People Limited is a provider of a cloud-based talent management platform designed to assist organizations in effectively managing various human resource functions. Founded in 1980 and headquartered in Melbourne, Australia, the company offers a comprehensive suite of services that includes recruitment, onboarding, performance management, learning and development, succession planning, and analytics. Its platform enables clients to streamline their talent management processes, providing tools for hiring, employee training, and career tracking. PageUp serves a diverse range of clients, including major organizations such as AEGIS, AngloAmerican, and National Australia Bank, and has established additional offices in Sydney, Singapore, Hong Kong, New York, and London.

Neara provides a cloud-based platform designed for the electric and power infrastructure industry, focusing on predictive modeling software. This platform allows utilities to proactively manage their networks by simulating severe weather scenarios and identifying vulnerabilities within their systems. By employing predictive algorithms, Neara offers a three-dimensional, physics-enabled model that enhances visualization and reporting for energy businesses. This capability aids in optimizing asset management across the entire network, ensuring informed decision-making and improved governance of utility operations.

Vinted is an online marketplace that focuses on promoting second-hand fashion as a preferred choice for consumers. The platform allows users, primarily targeting girls and women, to buy, sell, and swap clothing, accessories, and lifestyle items in a peer-to-peer environment. Vinted enhances the shopping experience by incorporating an online chatting feature, facilitating communication between users and making transactions simpler and more efficient. With a mobile-first approach, Vinted aims to make second-hand shopping accessible and cost-effective for its community.

OX2 is a renewable energy company that develops, constructs, and operates solar and wind farms, along with energy storage solutions. It manages projects across Europe, including Sweden, Finland, Poland, France, Lithuania, Norway, Spain, Italy, Estonia, and Romania.

Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

Indostar Home Finance is a housing finance company that provides mortgages to retail clients in tier 2 to tier 4 cities and has supported low-income homeowners and small companies.

PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.

GeBBS Healthcare Solutions is a technology-enabled company that provides revenue cycle management (RCM) solutions to improve financial performance, compliance, and patient satisfaction. Founded in 2005 and headquartered in Culver City, California, GeBBS offers a range of services including Health Information Management (HIM), Revenue Cycle Management (RCM), Patient Access, Risk Adjustment Solutions, strategic outsourcing, and consulting services. The company serves hospitals, physician groups, health plans, and medical billing companies. With over 6,000 employees globally, GeBBS has formed strategic partnerships with various industry associations and organizations.

Compass Education is a cloud-based school management platform designed to enhance parent engagement while reducing administrative burdens for educational institutions. Operating in regions including Victoria, New South Wales, Brisbane, and Dublin, the platform offers a versatile student information system that supports multiple languages and currencies. It features a wide array of modules, including attendance tracking, reporting, parent communication, student well-being, and learning management. Additionally, Compass Education facilitates staff development, online payments, event management, and data analytics, enabling schools to streamline their processes. By allowing administrators to efficiently manage school data and generate reports, the platform helps them focus on fostering strong connections within the school community.

PropertyGuru Limited is a property technology company based in Singapore, operating online property classifieds marketplaces across Singapore, Vietnam, Malaysia, Thailand, and Indonesia. Established in 2006, it serves as a vital platform for agents and developers to advertise residential and commercial properties for sale or rent, connecting them with property seekers. The company features a flagship website, PropertyGuru.com.sg, which attracts over 4.5 million consumers who engage with more than 50 million pages. In addition to its marketplace services, PropertyGuru offers digital marketing solutions for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, as well as property data consultancy services aimed at banks, valuers, and property developers. Its operations are segmented into distinct geographic markets and include fintech and data services, solidifying its position as a key player in the property technology sector in Southeast Asia.

KJ Environment is an environmental and energy infrastructure specialist is establishing a scaled and diverse end-to-end waste treatment platform focusing on plastic recycling and waste-to-electricity conversion.

AMCS Group is an Irish company headquartered in Limerick, specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Founded in 2002 by James Martin and Austin Ryan, AMCS offers a comprehensive range of products, including RFID technology, weighing systems, and ERP software, which facilitate efficient management of operations such as bin, vehicle, and skip management. The company’s platform is designed to standardize and optimize business processes, enabling clients to reduce operating costs, enhance asset utilization, and improve customer service. AMCS Group serves a diverse clientele, including municipalities, private recycling firms, and commercial waste haulers, helping them transition towards a circular economy for better resource management and logistics.

Acronis, Inc. is a global provider of backup software, disaster recovery, and secure data access solutions, catering to consumers, small to medium-sized businesses, and enterprises. Established in 2000 and headquartered in Woburn, Massachusetts, Acronis offers a comprehensive range of services, including physical, virtual, and cloud server backup solutions, as well as storage management and secure file sharing. The company's innovative Acronis AnyData engine delivers protection across various devices and environments, while its Acronis Cyber Protect solution integrates data protection with cybersecurity to address safety, accessibility, privacy, authenticity, and security challenges. Acronis employs advanced technologies, including AI-driven anti-malware and blockchain-based data authentication, to safeguard data in cloud, hybrid, and on-premises settings. With a workforce of over 2,000 employees and a presence in 45 locations, Acronis serves a diverse clientele across sectors such as public services, healthcare, and publishing, supporting more than 750,000 businesses worldwide.

Asceneuron SA is a biotechnology company based in Lausanne, Switzerland, founded in 2012, that focuses on discovering and developing therapeutics for neurodegenerative disorders with significant unmet medical needs. The company targets conditions such as progressive supranuclear palsy, orphan tauopathies, Alzheimer’s disease, and Parkinson’s disease. Asceneuron aims to develop orally bioavailable small molecule drugs that address both symptomatic relief and disease progression for these debilitating conditions. Tauopathies, characterized by the accumulation of tau protein deposits in the brain, are a key area of focus, as they currently lack effective treatments. With the increasing prevalence of Alzheimer's disease posing a major healthcare challenge, Asceneuron aspires to become a leading entity in the biotech sector by providing innovative and more effective therapeutic options for patients suffering from neurodegenerative diseases. The company operates as a subsidiary of Merck KGaA.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Peak3 is a developer of insurtech software that delivers technical solutions and professional services to businesses. The company focuses on providing digital insurance options that are affordable and easily accessible, catering to the increasing demands of on-demand customers. By leveraging digital ecosystems, Peak3 enables users to redefine the insurance landscape and seamlessly integrate relevant protection into their customer journeys. Through its innovative platform, Peak3 aims to simplify the insurance process and enhance the overall experience for users.

Perficient is an information technology consulting firm that specializes in software development and digital consultancy services. The company assists clients in leveraging Internet-based technologies to enhance productivity and competitiveness, while also strengthening relationships with customers, suppliers, and partners. Perficient offers a comprehensive range of services, including big data analytics, technology platform implementations, enterprise content management, portals and collaboration, management consulting, custom applications, business integration, business process management, and customer relationship management. It primarily serves clients in the healthcare, financial services, retail, and electronics industries, with most of its revenue generated in the United States.

WSO2 Inc. is a developer of an open-source enterprise middleware platform that facilitates digital transformation for organizations worldwide. Founded in 2005 and headquartered in Mountain View, California, with additional offices across various countries, WSO2 provides tools for enterprise architects to build, integrate, manage, secure, and analyze APIs, applications, and microservices across diverse environments, including on-premises and cloud settings. The company's offerings include WSO2 Developer Studio, WSO2 Private PaaS, and WSO2 App Cloud, which support application development and hosting, as well as customer identity and access management solutions. WSO2's API-first approach enables organizations to efficiently harness their APIs, enhancing user experiences while managing over 1 billion identities and executing trillions of transactions annually. The company serves multiple sectors, including healthcare, finance, retail, and technology, positioning itself as a significant player in the digital landscape.

Universidad Europea is an innovative educational institution focused on enhancing societal value and progress. It operates a network of schools and offers a range of undergraduate and graduate programs designed to prepare students for the modern job market. The institution emphasizes an international perspective in its curriculum, aiming to equip students with the necessary skills and knowledge for personal and professional development. Through its commitment to high-quality education, Universidad Europea seeks to foster opportunities that lead to successful careers for its graduates.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Avetta, LLC is a software company specializing in supply chain risk management through its SaaS platform designed for managing suppliers, contractors, and vendors. The company offers a suite of solutions, including PICS Organizer for collecting and analyzing contractor information, DocuGUARD for verifying contractor forms, and InsureGUARD for reviewing insurance certificates. Additionally, Avetta provides AuditGUARD for various auditing solutions and EmployeeGUARD for assessments at the employee level. The Enterprise Organizer enhances communication and contractor management, while GUARDBuilder allows customization of contractor information tracking. Serving a diverse range of industries such as oil and gas, pharmaceuticals, and construction, Avetta connects organizations with qualified suppliers to promote safety and sustainability. Founded in 2003 and based in Orem, Utah, Avetta operates additional offices worldwide, reflecting its commitment to global service and innovation in contractor management. The company was formerly known as PICS Auditing, LLC until its rebranding in 2016.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.

Phagenesis Limited is focused on developing medical device technology aimed at treating dysphagia, a condition that impairs swallowing, often resulting from strokes or brain injuries. The company's primary product, Phagenyx, consists of a base station that delivers electrical stimulations to the patient and records pertinent information, along with a catheter that is introduced through the nose to stimulate the pharynx. This innovative approach leverages the brain's ability to relearn lost functions through neuroplasticity, effectively aiding patients in regaining control over their swallowing mechanisms. Founded in 2007 and based in Manchester, United Kingdom, Phagenesis emphasizes research and evidence-based solutions, with foundational work led by Professor Shaheen Hamdy of the University of Manchester, whose findings have been published in prestigious medical journals.

Believe is a digital distributor focused on independent music, dedicated to supporting local artists and labels throughout their digital journeys. The company operates primarily through two segments: Premium Solutions and Automated Solutions. Premium Solutions involves the sale, promotion, and delivery of digital content for artists and labels, where Believe develops their catalogs across various digital platforms and social media, utilizing a revenue-sharing model. In contrast, Automated Solutions allows artists to distribute their audio content through the TuneCore platform, enabling a more streamlined and automated approach to reaching streaming services and social media. By prioritizing justice, expertise, respect, and transparency, Believe aims to empower independent musicians and enhance their visibility in the digital landscape.

Onera Health, Inc. specializes in providing innovative sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, Onera Health has developed advanced sleep diagnostic patch systems that collect and analyze sleep data. These systems not only enhance the diagnosis of sleep-related ailments but also have potential applications in monitoring various chronic health conditions. By delivering comprehensive sleep test data to healthcare providers, Onera Health aims to improve patient care and reduce healthcare costs, ultimately enhancing the health and quality of life for individuals globally.

InstaVolt Ltd is a prominent provider of electric vehicle (EV) charging infrastructure in the United Kingdom, established in 2016 and headquartered in Basingstoke. The company focuses on the development, installation, ownership, and operation of rapid charging stations strategically located at retail and food sites, as well as fuel forecourts. By offering an open charger model, InstaVolt allows users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards, addressing concerns such as range anxiety that potential EV owners often face. The company aims to facilitate the transition to electric vehicles by making charging quick and accessible, thereby contributing to improved air quality and reduced carbon emissions across the UK. InstaVolt also provides landowners with opportunities to earn rental income by hosting their charging units, thereby fostering a collaborative approach to building the necessary infrastructure for a sustainable future.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Indium Software is a rapidly expanding digital engineering services company that specializes in delivering innovative solutions in applications and data. The firm leverages advanced technologies, including Generative AI and data analytics, to offer a wide array of services such as Low-Code Development, Data Engineering, AI/ML, and Quality Engineering. Indium's expertise extends to various domains, including application engineering, cloud engineering, DevOps, digital assurance, and gaming. By focusing on these next-generation offerings, Indium aims to help clients effectively harness technology to achieve measurable business outcomes.

Next One Technology operates within the cloud management and information technology sectors, focusing on the construction, contracting, and service industries. The company develops cloud-based systems, including Next Project and Next Field, which are designed to streamline project administration and enhance control over financial and payroll processes for businesses of all sizes. By providing user-friendly tools and environments, Next One Technology aims to improve efficiency, facilitate growth, and increase profitability for its clients. Additionally, the company is dedicated to making technology education accessible, offering resources that enable individuals to learn tech skills and upskill software teams, thus simplifying developer workflows.

HVD Group offers cloud-based end-to-end field service management and enterprise resource planning software with key functionalities such as order, project and asset management, scheduling, time reporting, procurement and documentation handling.

Zeus Industrial Products is a manufacturer specializing in polymer extrusion and material science innovation. The company provides a diverse range of products, including fluoropolymers, custom extruded items, and specialized heavy construction products. Additionally, Zeus offers heavy wall and convoluted products, as well as PTFE and FEP heat shrink products. Their expertise in these areas positions them as a key player in the polymer industry, catering to various industrial needs.

LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. By leveraging advanced four-dimensional imaging and artificial intelligence, LUMA Vision aims to transform electrophysiology and structural heart interventions. Their technology facilitates real-time tissue analysis, enabling healthcare professionals to perform cardiac procedures more effectively. This innovation is designed to improve patient outcomes, enhance procedural safety, and ultimately lower costs within the healthcare system.

Shinobi Therapeutics specializes in the development of cell therapies that leverage hypoimmune CD8αβ iPS-T cells to interact with the immune system for the treatment of cancer and various genetic diseases. The company's innovative approach incorporates advanced immune evasion technology to enhance the effectiveness and accessibility of these therapies. By focusing on durable responses and the potential for redosing, Shinobi aims to reduce costs and improve patient outcomes in the healthcare sector.

Heritage Environmental Services is a privately held environmental services firm based in Indianapolis, Indiana, with over 45 years of experience in the industry. The company specializes in providing a range of environmental management and consultancy services. Its offerings include waste treatment, landfill disposal, logistics, laboratory testing, industrial maintenance, and regulatory training. Heritage is committed to assisting clients in navigating environmental challenges while ensuring compliance with regulations and promoting sustainable practices.

HRBrain, Inc. operates an online platform that delivers cloud-based human resource evaluation services. Founded in 2016 and headquartered in Tokyo, Japan, the company offers centralized management of human resource data, facilitating personal evaluations, organizational structure, and performance analysis. Its platform streamlines the management and assessment of employee goals, allowing businesses to set targets and evaluate performance efficiently. By visualizing and analyzing accumulated evaluation data, HRBrain enables companies and HR personnel to develop effective management strategies and measures, enhancing overall workforce management.

Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates modified viral vector vaccines for cancer treatment. The company utilizes a range of engineered viral vectors optimized for the effective expression of long strings of tumor neoantigens. Additionally, its platform includes tools designed to induce broad and potent antitumor T-cell responses, which aim to enhance cancer-specific cellular immunity in patients.

Statera Energy is a company focused on the development, ownership, and operation of energy infrastructure aimed at enhancing flexibility in the United Kingdom's electricity system. It generates, transmits, and distributes electric energy, utilizing in-house developed assets that include energy storage solutions and high-efficiency gas reciprocating engines. By managing these assets throughout their construction and operation, Statera Energy supports national grid operators, distribution network operators, and energy wholesalers in facilitating a transition to a low carbon energy landscape.

Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.

AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

VetPartners empowers their people to perform through education, guidance, support, simple processes and respectful relationships. They foster and create connection across their own network and the wider industry they work in. They are committed to doing what is right, being empathetic and supportive.

AstronauTx is a biotechnology company focused on developing treatments for Alzheimer's disease and other neurodegenerative conditions. The company aims to restore the normal functioning of astrocytes, which are crucial cells in the brain that support neuronal activity, metabolism, and the integrity of the blood-brain barrier. In conditions such as dementia, astrocytes can become dysfunctional, leading to neurotoxicity and exacerbating disease progression. By targeting astrocyte homeostasis, AstronauTx seeks to enable healthcare professionals to effectively address the underlying mechanisms of neurotoxicity associated with these diseases, ultimately improving treatment options for patients suffering from dementia and related disorders.

Wellhub is a corporate wellness platform designed to enhance employee engagement through improved physical activity. The company connects organizations with a diverse network of partners focused on fitness, emotional well-being, nutrition, and mindfulness. By offering a comprehensive subscription service, Wellhub enables employees to access various wellness options that promote lasting behavioral change and foster a healthier work environment. With over 2,000 clients, Wellhub is recognized for its ability to drive individual performance and overall business success by revolutionizing how employees engage in physical activity.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Dechra Pharmaceuticals PLC is a prominent developer and manufacturer of veterinary pharmaceuticals and related products, focusing on improving animal health and welfare. The company operates through three main segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. It provides a diverse range of products, including endocrinology, dermatology, analgesia, and anesthesia treatments for dogs and cats, as well as antibiotics and vaccines for poultry, pigs, and cattle. Additionally, Dechra offers nutrition products aimed at addressing various health conditions in pets, such as allergies and obesity. The company also distributes veterinary pharmaceuticals and equipment and provides related training and support services. Founded in 1997 and headquartered in Northwich, the United Kingdom, Dechra Pharmaceuticals markets its products through a network of wholesalers and distributors, emphasizing its commitment to enhancing animal health globally.

VarmX is a pharmaceutical spin-off from the Leiden University Medical Center focused on developing and manufacturing therapeutic proteins aimed at restoring blood clotting in patients experiencing severe bleeding. The company's lead product, PseudoXa, is a modified recombinant human coagulation factor X designed to work effectively in the presence of direct factor Xa anticoagulants like rivaroxaban, apixaban, and edoxaban. These anticoagulants are widely used for preventing and treating thrombosis and stroke but can lead to dangerous bleeding as a side effect. PseudoXa addresses this critical issue by providing a means to stop and prevent bleeding, thereby enhancing the safety of anticoagulant therapies for millions of patients worldwide.

Evommune, Inc. is a biotechnology company based in Los Altos, California, that focuses on developing and manufacturing tissue-based medicines aimed at treating inflammatory diseases. Founded in 2020, the company employs a proprietary tissue-based platform to accelerate the discovery of novel therapies, with a particular emphasis on immunology and dermatology. Evommune's approach seeks not only to alleviate the symptoms of inflammatory disorders but also to halt disease progression, thereby improving the quality of life for patients. Its pipeline includes initiatives targeting prevalent inflammatory conditions, with a commitment to advancing patient care by creating best-in-class treatment options. Through innovative strategies, Evommune aims to drive meaningful advancements in the field of inflammatory disease management.

Noya is focused on addressing climate change by retrofitting existing industrial equipment to capture carbon dioxide from the atmosphere. The company's innovative technology utilizes a non-toxic chemical blend that is added to the cooling towers of various industries without requiring any structural modifications. This approach allows for effective CO2 capture while enabling businesses to contribute to environmental sustainability. By selling the captured carbon dioxide to companies that utilize it as a raw material, Noya facilitates a practical and scalable solution for reducing carbon emissions and promoting a transition towards a carbon-negative future.

Lazer Logistics specializes in providing outsourced yard management services to a diverse range of industries, including food and beverage, consumer packaged goods, e-commerce retail, and pulp and paper. The company offers comprehensive solutions that include yard spotting, trailer shuttling, rental services, and staffing for gate personnel. By managing the movement of loaded and empty trailers within customer yards and offsite locations, Lazer Logistics ensures efficient operations at production and distribution sites. Additionally, they implement computerized yard management systems and provide training to enhance safety and streamline processes for their clients.

GotPhoto is a company that offers a software-as-a-service (SaaS) platform designed specifically for photographers, particularly those specializing in school and volume photography. By providing an efficient workflow and e-commerce solutions, GotPhoto enables photographers to sell their photos online seamlessly. The platform simplifies the process of managing photo sales, allowing photographers to focus on their creative work while effectively reaching their customers. With its user-friendly interface and tailored features, GotPhoto positions itself as a key player in the photography industry, facilitating online transactions and enhancing the overall experience for both photographers and their clients.

Tion Renewables is a European company specializing in renewable energy production. It operates a diverse portfolio of onshore wind and solar photovoltaic power plants, with a total installed capacity. The company's mission is to facilitate the transition to cleaner energy by generating power from renewable sources, thereby reducing reliance on fossil fuels.

IntegrityNext is a company based in Munich, Bayern, focused on providing a cloud-based platform for monitoring supplier sustainability and compliance. Established in April 2016 by Martin Berr-Sorokin, the platform allows businesses to automatically gather necessary supplier self-assessments and certifications while also monitoring social media for potential malpractice and reputational risks. Through its features, which include automated self-assessments, risk alerts, and a pre-built supplier questionnaire, IntegrityNext helps small and medium-sized enterprises navigate compliance data requirements set by international regulators. The platform's real-time dashboard and assessment framework enable companies to effectively manage compliance risks and streamline their processes.

QurAlis Corporation is a clinical-stage biotechnology company focused on discovering and developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Based in Cambridge, Massachusetts, the company utilizes proprietary platforms and biomarkers to create precision medicines targeting genetically validated disease-causing alterations. Its pipeline includes various treatments aimed at specific subtypes of ALS, such as therapies designed to restore dysfunctional cellular waste clearance, manage overactive neurons to prevent cell death, and eliminate toxic proteins. QurAlis aims to advance its antisense oligonucleotides and small molecule programs to address the most prevalent forms of ALS, ultimately working to halt disease progression and improve patient outcomes. The company was incorporated in 2016 and operates as a subsidiary of Q-State Biosciences, Inc.

SK Shielders provides cyber security, physical security, convergence security, and safety care services. They also offer caps home door guard, caps home inner guard, caps unmanned guard, mobile guard, infosec cloud guard, caps cyber guard, caps smart walk-in, caps smart check, caps view guard AI, and caps mobile access card.

Radius Global Infrastructure, Inc., headquartered in New York, specializes in the ownership and leasing of essential communications properties for wireless carriers and tower companies. Through its subsidiary, AP Wireless, the company manages a portfolio of ground, rooftop, and other critical sites that support the infrastructure necessary for cell site antenna systems. As of mid-2020, Radius held interests in approximately 6,600 leases across about 5,000 communication sites in the United States and 18 additional countries. Recognized as a significant international aggregator of rental streams in the wireless communications sector, Radius Global Infrastructure focuses on acquiring and managing telecom real property interests, which provides its clients with opportunities to expand into adjacent digital infrastructure markets.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

EQT is a global private equity and infrastructure firm founded in 1994, headquartered in Stockholm, Sweden. It specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies with strong growth potential. EQT invests across various sectors, including healthcare, technology, services, industrials, and real estate, with a particular emphasis on Northern and Eastern Europe, Asia, and the US. The firm seeks to unlock growth potential in its portfolio companies, positioning them as sustainable market leaders, and typically holds investments for four to eight years. EQT also prioritizes ESG and impact investments in its infrastructure portfolio.

Ontinue offers AI-powered Managed Extended Detection and Response (MXDR) services through its advanced security operations platform. This platform focuses on enhancing detection and response capabilities by leveraging artificial intelligence to improve communication and streamline processes. By providing innovative prevention services, Ontinue enables its clients to optimize operational efficiency and elevate the maturity of their security programs. The company's solutions are designed to meet the evolving security needs of organizations, ensuring robust protection against emerging threats.

Madison Energy Infrastructure is a platform that creates, owns, and manages renewable energy projects.

Cirba Solutions operates a circular supply chain focused on battery materials, utilizing a circular economy model that emphasizes recycling and resource reintroduction. The company collects end-of-life batteries and processes them to extract critical materials, which are then reintegrated into the supply chain. It provides a range of services, including battery inventory management, de-installation, and project management, tailored for corporations, governments, municipalities, and households. Additionally, Cirba Solutions offers battery-recycling systems and accessories to meet regulatory compliance needs and reduce landfill waste. The company's battery recycling management platform incorporates logistics and collection program solutions while ensuring environmental compliance through advanced technological processes.

SHL Medical AG specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989 and headquartered in Zug, Switzerland, the company serves pharmaceutical and biotech firms around the globe. In addition to its core product offerings, SHL Medical provides comprehensive services such as final assembly, labeling, and packaging. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring that it delivers innovative and reliable solutions tailored to meet the needs of its clients.

Trescal specializes in calibration and asset management services, offering a range of multi-brand solutions across various metrological domains. The company operates independently from original equipment manufacturers (OEMs), providing clients with calibration services that are designed to improve industrial performance. Trescal’s services are available both on-site and in dedicated laboratories, ensuring compliance with International Organization for Standardization (ISO) standards. By focusing on enhancing measurement processes, Trescal supports clients in achieving greater accuracy and efficiency in their operations.

Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Billtrust is a provider of cloud-based software that specializes in streamlining and automating accounts receivable (AR) processes for B2B commerce. The company addresses the inefficiencies of traditional AR methods, which often rely on outdated, manual, and paper-based practices. By offering a comprehensive order-to-cash platform, Billtrust facilitates the entire process from order receipt to payment collection, thereby enhancing revenue capture and cash flow for its clients. Its solutions encompass various functions, including credit decisioning, online ordering, invoicing, cash application, and collections. Billtrust integrates with multiple ecosystem players, such as financial institutions and enterprise resource planning systems, enabling customers to transition from costly paper invoicing to efficient electronic billing and payment methods. This transformation not only accelerates payment processing but also generates significant cost savings and improves the overall user experience.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.

United Talent Agency (UTA) is a talent and entertainment agency that represents actors, writers, directors, recording artists, and corporate brands across various industries such as film, television, music, digital media, and more. With a roster of high-profile clients including Johnny Depp, Harrison Ford, Jennifer Lopez, and many others, UTA specializes in providing representation for individuals and companies in the entertainment industry. In addition to talent representation, UTA also works with emerging technology companies and offers services in intellectual property, computer and video games, commercials, voiceovers, endorsements, and entertainment marketing.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

SPT Labtech is a manufacturer and designer of automated instrumentation and consumables for life science research. The company specializes in enhancing agility, efficiency, and productivity across various applications, including drug discovery, structural biology, molecular biology, and genomics. Its product portfolio focuses on minimizing assay volumes, streamlining workflows, and reducing material handling costs, thereby empowering life scientists to accelerate their research. SPT Labtech emphasizes collaboration and deep application knowledge, which informs its research and development efforts. The company is committed to addressing existing customer challenges through innovative solutions, driven by a strong ethos of customer-centricity. Additionally, its extensive expertise allows SPT Labtech to manage the entire life cycle of its products, from initial design and engineering to final manufacture and support, ensuring high-quality technical assistance and fostering strong client relationships.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers. 177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, is an antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.

Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company operates internationally with facilities in major locations such as Singapore, Dallas, Frankfurt, and Toronto, along with a network station in Hyderabad. Envirotainer serves a diverse clientele, including pharmaceutical and biotech companies, by offering a comprehensive suite of services that encompasses laboratory testing, qualification, validation support, and training through the Qualified Envirotainer Program. With over 30 years of experience, Envirotainer has established itself as a leader in secure cold chain solutions, ensuring that pharmaceutical products are transported in a controlled environment to meet the demands of the global market.

Redwood Capital Group, LLC leverages over 75 years of combined experience in the commercial real estate industry, targeting the acquisition and management of multi-family real estate. Its management team has handled in excess of eight billion dollars of commercial real estate investment, the lion’s share of which has been in multi-family assets. Our mission is to be the foremost choice for institutional and private equity in pursuit of strategic, multi-family investment. We deliver exceptional results to our investors and are uncompromising in our execution of strategy.

Guardian is the local Chinese pest control operator, with a strong presence in Eastern and Southern China.

BPEA EQT is a prominent private alternative investment firm headquartered in Hong Kong, with a substantial commitment of over USD 20 billion in capital. Established in 1997, the firm specializes in private equity investments, focusing on buyouts and providing growth capital to companies, particularly within the Asia Pacific region, while also seeking global opportunities that can leverage expansion into this market. BPEA EQT manages dedicated funds in private real estate and private credit, reflecting its diverse investment strategy. With a workforce of over 180 employees across offices in key countries including China, India, Japan, Australia, and Singapore, the firm oversees approximately 43 active portfolio companies in Asia, collectively employing over 224,000 individuals and generating sales of around USD 39 billion.

Ardoq AS, established in 2013 and headquartered in Oslo, Norway, with offices in New York, London, and Copenhagen, specializes in developing solutions to document and visualize complex computer systems. Its flagship product, Ardoq, combines textual documentation with interactive visualizations, offering features such as automatic visualization generation, real-time collaboration, and model-based documentation. Ardoq serves a wide range of professionals, including business users, developers, project managers, and stakeholders, empowering them to understand interdependencies, plan changes, and make data-driven decisions. The platform enables the entire organization to contribute to documentation, fostering a collaborative environment for digital transformation.

LSP is a defense and space company that specializes in providing strategy consulting services. The firm focuses on delivering expert guidance and insights to clients in the defense and aerospace sectors, helping them navigate complex challenges and develop effective strategies. Through its consulting services, LSP aims to enhance the operational efficiency and strategic positioning of its clients within the highly specialized defense and space industries.